Three-dimensional Differentiated Human Mesenchymal Stem Cells Exhibit Robust Antifibrotic Potential and Ameliorates Mouse Liver Fibrosis
Recently, three-dimensional (3D)-cultured adipose mesenchymal stem cells (ASCs) have provided an effective therapy for liver fibrosis. This study aimed to enhance the potential of human ASCs for antifibrosis or hepatocyte regeneration using a 3D culture system and investigate their therapeutic mecha...
Main Authors: | Ja Sung Choi, Young-Jin Park, Sung-Whan Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2021-02-01
|
Series: | Cell Transplantation |
Online Access: | https://doi.org/10.1177/0963689720987525 |
Similar Items
-
Antifibrotic Effect of Casticin on Liver Fibrosis Casued by Schistosoma mansoni in Mouse Model
by: LAN, YI-CHIA, et al.
Published: (2019) -
Pilot study of the antifibrotic effects of the multikinase inhibitor pacritinib in a mouse model of liver fibrosis
by: Al-Fayoumi S, et al.
Published: (2018-05-01) -
Antifibrotic Effect of Marine Ovothiol in an In Vivo Model of Liver Fibrosis
by: Mariarita Brancaccio, et al.
Published: (2018-01-01) -
Antifibrotic effects of crocin on thioacetamide-induced liver fibrosis in mice
by: Mardi M. Algandaby
Published: (2018-05-01) -
Secreted matrix metalloproteinase-14 is a predictor for antifibrotic effect of IC-2-engineered mesenchymal stem cell sheets on liver fibrosis in mice
by: Kenji Fukushima, et al.
Published: (2021-12-01)